Acute Bacterial Epididymitis Diagnosis and Treatment

Clinical Presentation and Diagnosis

• The European Urology guidelines suggest that patients with acute epididymitis typically present with testicular pain, and in this case, the patient has left testicular pain for 8 days with recent exacerbation, which is consistent with the diagnosis of acute epididymitis 1
• The presence of lower abdominal pain suggests extension of the inflammatory process, which is a common finding in acute epididymitis 1
• The absence of irritative urinary symptoms does not rule out urinary tract infection, as seen in this patient 1
• The patient's laboratory findings, including elevated PCR (48 mg/L) and microscopic hematuria (4-6 red blood cells per field), indicate an active infection and support the diagnosis of acute epididymitis 1
• Leukocytosis with neutrophilia (78.9% neutrophils) is also present, which is a common finding in bacterial infections, including acute epididymitis 2

Treatment Recommendations

• The European Urology guidelines recommend treating acute epididymitis with antibiotics, such as levofloxacino 500 mg orally once daily for 10 days, or alternatively, ceftriaxona 250 mg IM single dose plus doxiciclina 100 mg orally twice daily for 10 days 1
• Nitrofurantoína and fosfomicina oral are not recommended for the treatment of acute epididymitis due to inadequate tissue penetration and lack of efficacy 3

Management and Follow-up

• The patient should be advised to have relative rest, scrotal elevation, and use a scrotal supporter to reduce edema 1
• Anti-inflammatory medications can be used to control pain 1
• Re-evaluation should be done at 48-72 hours to confirm improvement, and if no improvement is seen after 72 hours of appropriate antibiotic treatment, further evaluation with ultrasonography and consideration of changing antibiotics based on culture and sensitivity results should be done 1
• A urine culture with antibiogram should be performed before starting antibiotics to guide therapeutic adjustments if necessary 3
• Ultrasonography of the testicles should be considered if there is diagnostic doubt or lack of response to treatment 1

Epididymitis Diagnosis and Treatment

Diagnostic Assessment

• The Centers for Disease Control and Prevention recommends that patients with symptoms suggestive of epididymitis, such as weak urinary stream, numb sensation, groin and right thigh pain, and penile numbness, should be evaluated for sexually transmitted pathogens, which are the most common cause of epididymitis in men under 35 years of age 4, 5
• In sexually active men under 35 years, the most common causative organisms are Chlamydia trachomatis and Neisseria gonorrhoeae, according to the Centers for Disease Control and Prevention 4, 6
• Diagnostic evaluation should include a Gram-stained smear of urethral exudate for diagnosis of urethritis and presumptive diagnosis of gonococcal infection, as recommended by the Centers for Disease Control and Prevention 5
• Culture or nucleic acid amplification test for N. gonorrhoeae and C. trachomatis should be performed, as recommended by the Centers for Disease Control and Prevention 4

Treatment Recommendations

• The Centers for Disease Control and Prevention recommends ceftriaxone 250 mg IM in a single dose PLUS doxycycline 100 mg orally twice a day for 10 days for epididymitis most likely caused by gonococcal or chlamydial infection in men under 35 years 4, 5
• For epididymitis likely caused by enteric organisms, the Centers for Disease Control and Prevention recommends ofloxacin 300 mg orally twice a day for 10 days OR levofloxacin 500 mg orally once daily for 10 days 4, 6

Important Considerations

• The European Association of Urology's 2024 guidelines support the use of ceftriaxone plus doxycycline as first-line therapy for sexually transmitted epididymitis in younger men 6
• The Centers for Disease Control and Prevention and the European Association of Urology do not recommend Bactrim DS (trimethoprim-sulfamethoxazole) for epididymitis treatment in this age group 4, 5, 6

Epididymitis Diagnosis and Treatment

Age-Dependent Diagnostic Approaches

• In sexually active men aged 14-35 years, the most common pathogens are Chlamydia trachomatis and Neisseria gonorrhoeae, which cause urethritis-associated epididymitis, frequently presenting without significant pyuria, according to the Centers for Disease Control and Prevention (CDC) 7
• The diagnostic evaluation should include urethral swab testing rather than relying solely on urinalysis, as recommended by the CDC 7, 8

Diagnostic Testing

• Current tests for C. trachomatis are not sufficiently sensitive to exclude infection even when negative, as noted by the CDC 8
• Relying solely on urinalysis misses the majority of STI-related epididymitis cases in younger men, as these infections originate from urethral pathogens rather than urinary tract bacteria, according to the CDC 7

Proper Diagnostic Approach by Age

• For men <35 years (sexually active), the CDC recommends obtaining urethral Gram stain or intraurethral swab for urethritis diagnosis, and performing nucleic acid amplification testing (NAAT) for N. gonorrhoeae and C. trachomatis on intraurethral swab or first-void urine 7
• For men >35 years, urine culture and Gram-stained smear are more likely to be diagnostic, and the CDC recommends looking for enteric organisms, particularly in patients with recent urinary instrumentation, surgery, or anatomical abnormalities 7, 8

Treatment Implications

• In sexually active men <35 years with negative urinalysis, empiric treatment for STIs is still indicated, with the CDC recommending ceftriaxone 250 mg IM single dose PLUS doxycycline 100 mg orally twice daily for 10 days 7
• If no improvement occurs within 3 days of appropriate treatment, the CDC recommends reevaluating both diagnosis and therapy, and considering alternative diagnoses including testicular torsion, tumor, abscess, or testicular cancer 7

Epididymitis Clinical Presentation and Diagnosis

Core Clinical Presentation

• The Centers for Disease Control and Prevention recommends that epididymitis typically presents with gradual onset of unilateral testicular pain and tenderness, with palpable swelling of the epididymis that usually begins at the lower pole and progresses upward toward the upper pole of the testis 9
• The American College of Radiology notes that testicular pain is unilateral, gradual onset over hours to days, located posteriorly in the scrotum 9, 10
• The European Urology association reports that epididymal swelling and tenderness is characterized by palpable enlargement starting at the lower pole, progressing to the upper pole 9
• Scrotal swelling and erythema may develop as inflammation progresses, according to the European Urology and American College of Radiology 10, 11
• Elevated scrotal temperature is indicated by local warmth over the affected area, as noted by the European Urology association 11

Associated Urogenital Symptoms

• The Centers for Disease Control and Prevention recommends that urethritis symptoms, such as urethral discharge, dysuria, or urinary frequency, may accompany sexually transmitted epididymitis in younger men 9
• The American College of Radiology notes that urinary tract symptoms, such as dysuria, urinary frequency, urgency, weak stream, or hesitancy, are related to bladder outlet obstruction in older men 9

Key Distinguishing Clinical Signs

• The American College of Radiology reports that a positive Prehn sign, where pain relief is experienced when elevating the scrotum over the symphysis pubis, helps differentiate epididymitis from testicular torsion 10
• The European Urology association notes that reactive hydrocele may develop as inflammation and edema progress 10
• Fever can occur in severe cases, indicating systemic involvement, as reported by the European Urology association 11

Systemic Symptoms Requiring Urgent Evaluation

• The European Urology association recommends that systemic illness, such as high fever, rigors, nausea, vomiting, indicates possible abscess or Fournier's gangrene 11
• Scrotal skin changes, such as crepitus, necrosis, or rapidly spreading erythema, suggest necrotizing infection, as noted by the European Urology association 11

Diagnostic Criteria for Epididymitis

Clinical Presentation

• The Centers for Disease Control and Prevention recommends diagnosing epididymitis based on unilateral testicular pain and tenderness with palpable epididymal swelling, supported by urinalysis showing pyuria and urine culture for enteric organisms, after excluding testicular torsion 12, 13
• Gradual onset of posterior scrotal pain over hours to days is a key symptom to identify, distinguishing it from the sudden onset of testicular torsion 14
• Unilateral testicular pain and tenderness localized to the epididymis, typically beginning at the lower pole and progressing upward, is a characteristic presentation 12
• A positive Prehn sign, where pain is relieved when elevating the scrotum over the symphysis pubis, helps differentiate epididymitis from torsion 14

Age-Specific Diagnostic Approach

• For men over 35 years, the American College of Radiology suggests that Gram-negative enteric bacteria, particularly E. coli, are the predominant pathogens, and urinalysis and urine culture are essential diagnostic tests 15
• For younger men (14-35 years), the Centers for Disease Control and Prevention recommends that Chlamydia trachomatis and Neisseria gonorrhoeae are primary pathogens, and urethral swab testing with nucleic acid amplification test (NAAT) is required 12, 15

Required Diagnostic Evaluation

• The Centers for Disease Control and Prevention recommends performing urinalysis examining first-void uncentrifuged urine for leukocytes (pyuria) 12, 13
• Urine culture and Gram stain for Gram-negative bacteria are also recommended 12, 15
• Doppler ultrasound may be used if diagnosis is uncertain or to rule out testicular torsion, abscess, or other complications 14

Critical Differential Diagnosis

• Testicular torsion must be excluded immediately, as it is a surgical emergency, and the American College of Radiology suggests that sudden onset of severe pain and negative Prehn sign are key distinguishing features 12, 14
• Emergency surgical consultation is required if diagnosis is questionable, as testicular viability is compromised within 6-8 hours 12, 14

Common Pitfalls

• Failure to exclude testicular torsion can result in testicular loss, and the Centers for Disease Control and Prevention recommends maintaining high suspicion with sudden onset or severe pain 12, 14
• Inadequate follow-up, where no improvement is seen within 3 days of treatment, warrants re-evaluation of both diagnosis and therapy 12, 13

Acute Epididymitis: Inflammatory Pain Mechanism and Evidence‑Based Management

Pain Mechanism

• The pain of acute epididymitis is inflammatory (nociceptive) rather than neuropathic, arising from bacterial infection that triggers tissue inflammation and the release of mediators such as prostaglandins and cytokines which activate peripheral nociceptors in the epididymal tissue【16】.

Antibiotic Regimens (Age‑Based)

• For men < 35 years, the CDC MMWR recommendation is to treat with a single intramuscular dose of ceftriaxone plus a 10‑day course of doxycycline to cover Neisseria gonorrhoeae and Chlamydia trachomatis【16】.
• For men ≥ 35 years, a fluoroquinolone (e.g., levofloxacin or ciprofloxacin) for 10 days is recommended to target typical uropathogens such as Escherichia coli【16】.

Expected Clinical Response

• Pain should begin to improve within 3 days of initiating appropriate antibiotic therapy; lack of improvement warrants reassessment of the diagnosis and consideration of alternative causes【16】.

Evaluation of Persistent or Recurrent Pain

• If pain persists after completing the antimicrobial course, clinicians should systematically re‑evaluate for other conditions—including scrotal tumor, epididymal abscess, testicular cancer, or progression to chronic epididymitis—rather than attributing the symptoms to neuropathic pain【16】.

Strength of evidence: not explicitly graded in the source; recommendations are based on CDC MMWR consensus guidance.

Management of Acute Epididymo‑Orchitis – Evidence‑Based Recommendations

Empiric Antibiotic Therapy

• Men < 35 years (suspected sexually transmitted etiology) – The CDC MMWR recommends a single intramuscular dose of ceftriaxone 250 mg plus doxycycline 100 mg orally twice daily for 10 days to provide dual coverage for Neisseria gonorrhoeae and Chlamydia trachomatis【17】.
• Common pathogens in this age group – C. trachomatis and N. gonorrhoeae are the predominant organisms, justifying the dual‑therapy regimen【17】【18】.
• Men ≥ 35 years (suspected enteric etiology) – The CDC MMWR recommends either ofloxacin 300 mg orally twice daily or levofloxacin 500 mg orally once daily for 10 days, targeting gram‑negative enteric bacteria such as Escherichia coli【17】.
• Enteric pathogens in older men – E. coli is the most frequent causative organism in this population【17】.

Diagnostic Evaluation Prior to Antibiotics

• Urethral Gram stain – Perform to detect urethritis (≥ 5 polymorphonuclear leukocytes per high‑power field) and to make a presumptive diagnosis of gonorrhea【17】.
• Nucleic‑acid amplification test (NAAT) – Obtain from a urethral swab or first‑catch urine to identify N. gonorrhoeae and C. trachomatis【17】.
• First‑catch urine microscopy – Examine uncentrifuged specimen for leukocytes when the urethral Gram stain is negative【17】.
• Serologic testing – Screen for syphilis and provide HIV counseling/testing as part of the work‑up【17】.

Supportive (Adjunctive) Care

• Bed rest, scrotal elevation, and analgesia – Recommend these measures until fever and local inflammation have resolved【17】.

Follow‑up and Reassessment

• Early reassessment – If no clinical improvement is observed within 3 days of therapy initiation, re‑evaluate both the diagnosis and the antimicrobial regimen【17】.
• Criteria for improvement – Expect reduction in pain, swelling, and tenderness as markers of therapeutic response【17】.
• Persistent findings after treatment – Ongoing swelling or tenderness warrants investigation for complications such as abscess, infarction, tumor, tuberculosis, or fungal epididymitis【17】.
• Structured follow‑up – A mandatory evaluation at 72 hours is essential to detect early complications【17】.

Management of Sexual Partners

• Partner notification – Patients with confirmed or suspected gonococcal or chlamydial epididymo‑orchitis should advise all sexual partners from the preceding 60 days to seek evaluation and treatment【17】【18】.
• Empiric partner therapy – Partners receive a regimen covering both N. gonorrhoeae and C. trachomatis, irrespective of the index patient’s identified pathogen【18】.
• Abstinence until cure – Patients must refrain from sexual activity until they and their partners have completed therapy and are symptom‑free【17】.

Special Populations

• Patients with HIV – Non‑complicated epididymo‑orchitis in HIV‑positive individuals is treated with the same regimens recommended for HIV‑negative patients; however, clinicians should consider fungal and mycobacterial causes more frequently in this group【17】.

Risk Factors for Enteric (Gram‑Negative) Etiology

• Age ≥ 35 years
• Recent urinary instrumentation
• Known urinary‑tract anomalies
• Benign prostatic hyperplasia
• Receptive anal intercourse
• Positive urine culture with leukocytes and nitrites

Common Pitfalls to Avoid

• Monotherapy in men < 35 years – Single‑agent therapy (e.g., ciprofloxacin alone) fails to provide adequate coverage for both gonorrhea and chlamydia; dual therapy is required【17】.
• Failure to obtain cultures before antibiotics – Urine culture with susceptibility testing is crucial for tailoring therapy when the initial regimen is ineffective【17】.

All recommendations are derived from the CDC MMWR (2002) and reflect the strength of evidence as presented in the source documents.